MCKINLEY CAPITAL MANAGEMENT LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
MCKINLEY CAPITAL MANAGEMENT LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2019$44,000
-94.5%
1,198
-93.5%
0.00%
-95.4%
Q4 2018$798,000
-6.8%
18,519
+2.1%
0.06%
+20.4%
Q3 2018$856,000
-10.6%
18,133
-5.7%
0.05%
-12.9%
Q2 2018$957,000
+1814.0%
19,223
+1797.6%
0.06%
+1966.7%
Q1 2018$50,0001,0130.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders